MedPath

The effect of vaginal probiotic capsule on fertility in wome

Phase 2
Conditions
Recurrent implantation failure.
Complication associated with artificial fertilization, unspecified
N98.9
Registration Number
IRCT20160422027520N21
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
200
Inclusion Criteria

Patients from East Azerbaijan
Having at least three implantation failures after IVF/ICSI
Having primary infertility
The thickness of the endometrium on the day of ovulation induction with HCG should be less than 6 mm
Having regular menstrual cycles
BMI under 30
Do not have any type of immunotherapy in their medical history.

Exclusion Criteria

Patients under 18 years old and over 41 years old
Having polycystic ovarian syndrome
Poor ovarian reserve
Having chromosomal abnormalities
Positive HIV, HCV or HBV tests
Patients with intrauterine anomalies.
Patients with coagulation problems.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy rate. Timepoint: After positive beta-hCG test, clinical pregnancy was evaluated at 5-6 week. Method of measurement: Examining the formation of gestational sac using Sonography method.;Live birth rate. Timepoint: 9 months. Method of measurement: People with positive ß-hCG test after treatment will be continuously monitored with the help of gynecologists. After about 9 months, we will evaluate the number of babies born.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath